Latest News and Press Releases
Want to stay updated on the latest news?
-
BALTIMORE, May 02, 2023 (GLOBE NEWSWIRE) -- MarketWise, Inc. (NASDAQ: MKTW) (“MarketWise” or the “Company”) today announced that it has entered into a settlement agreement with F. Porter Stansberry...
-
SPARTANBURG, S.C., May 02, 2023 (GLOBE NEWSWIRE) -- Denny’s Corporation (the "Company") (NASDAQ: DENN), owner and operator of Denny's Inc. ("Denny's") and Keke's Inc. ("Keke's") today reported...
-
NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”) (Nasdaq: SSSS) today announced that it will report its financial results for the quarter ended March 31, 2023 after...
-
COVINGTON, La., May 02, 2023 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq:POOL) announced today that Peter D. Arvan, President and Chief Executive Officer, and Melanie M. Hart, Vice President and...
-
LOS ANGELES, May 02, 2023 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ: HNST), a digitally-native consumer products company born in the Gen Z era to make purpose-driven consumer products designed...
-
PEMBROKE, Bermuda, May 02, 2023 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) today reported first quarter 2023 net income available to common...
-
25+ year veteran Iyer has successfully led growth of businesses in India, Southeast Asia and AfricaMaurizio Brusadelli to leave company in June to pursue external leadership opportunity CHICAGO,...
-
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the treatment and prevention of virus-associated cancers that impact...
-
B2B payor sessions grew 90% year-over-year 1Q 2023 Operating expenses of $25.8 million, down 29% year-over-year 1Q 2023 Net loss of $8.8 million; Narrowed Adjusted EBITDA1 loss to $6.4 million, down...
-
BRIDGEWATER, N.J., May 02, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology company developing therapeutic candidates targeting...